(Q53658719)

16 May 2018

title

Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status. (English)

1 reference

16 May 2018

author name string

Smriti M Krishna

series ordinal

1

1 reference

16 May 2018

Susan James

series ordinal

2

1 reference

16 May 2018

Prabha Balaram

series ordinal

3

1 reference

16 May 2018

publication date

1 September 2005

1 reference

16 May 2018

published in

Virus Research

1 reference

16 May 2018

volume

115

1 reference

16 May 2018

issue

1

1 reference

16 May 2018

page(s)

85-90

1 reference

16 May 2018

Clinical relevance of amphiregulin and VEGF in primary breast cancers

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.07.010

The vascular endothelial growth factor family of polypeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.07.010

The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.07.010

Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.07.010

Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.07.010

Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.07.010

Nasopharyngeal carcinomas: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.07.010

Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.07.010

Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.07.010

7 January 2021

Nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.07.010

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.07.010

Association of vascular endothelial growth factor expression with angiogenesis and lymph node metastasis in nasopharyngeal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.07.010

Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.07.010

Epstein-Barr virus and oncogenesis: from latent genes to tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.07.010

Alterations of Biologic Properties and Gene Expression in Nasopharyngeal Epithelial Cells by the Epstein-Barr Virus–Encoded Latent Membrane Protein 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.07.010

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIRUSRES.2005.07.010

1 reference

16 May 2018

PubMed ID

16139912

1 reference

16 May 2018